戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  2, which are potentially exploitable by any hospital laboratory.
2 rticipants were taken before the walk in the hospital laboratory.
3 f gram-negative organisms encountered in the hospital laboratory.
4 to assess feasibility and performance in the hospital laboratory.
5 and with other HPLC assays currently used in hospital laboratories.
6 or HIV according to standard practice in the hospital laboratories.
7 logy laboratory and, in some cases, at local hospital laboratories.
8 tients and 12 environmental isolates from 24 hospital laboratories across the United Kingdom on an Il
9 overed in cultures obtained at six different hospital laboratories across the United States.
10 rove the diagnostic accuracy and capacity of hospital laboratories, allowing for timely and appropria
11                         Overall, nonacademic hospital laboratories and pediatric-only laboratories ar
12 e laboratory were compared with those of the hospital laboratories and risk of transfusion-associated
13 re cultured from patient infections in 71 US hospital laboratories and were submitted to a central re
14 ncluding primary and secondary care centres, hospitals, laboratories, and universities) in Latin Amer
15             Patients were identified through hospital laboratory-based surveillance or through the Te
16 rveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 ho
17                    By combining these tools, hospital laboratories can improve early detection of H5N
18 g a tightly clustered set of isolates from 3 hospital laboratories consistent with an outbreak from a
19  and body mass index were collected from the hospital laboratory database.
20 g conducted in 11 of the participating ICARE hospital laboratories failed to pinpoint the factors res
21                      They were referred to a hospital laboratory for an urinalysis, complete blood co
22 vely that were examined independently by the hospital laboratory for the presence of the Demodex mite
23 specimens collected from children at 11 U.S. hospital laboratories from November 1997 to March 1998 a
24                     Data were produced by 25 hospital laboratories in France.
25 rent control measures; isolates from 7 other hospital laboratories in London and southeast England we
26 . soudanense that were processed in a single hospital laboratory in Baltimore, Maryland, between 1 Ja
27 l age groups from its outpatient, inpatient, hospital laboratory, laboratory network, and surgical si
28                      There are concerns that hospital laboratories may have inadequate surge capaciti
29 ood culture-confirmed enteric fever from the hospital laboratories not captured by inpatient or outpa
30           Currently, testing is performed in hospital laboratories or with expensive point-of-care de
31 heid, Sunnyvale, CA) performed at a district hospital laboratory or (2) POC Xpert MTB/RIF test perfor
32 r commercial HMO enrollees for professional, hospital, laboratory, pharmaceutical, and ancillary serv
33 dy investigators, paediatricians in referral hospitals, laboratory staff, and committee members were
34 due to rotavirus disease was estimated using hospital laboratory surveillance data.
35 consider the diagnosis on presentation, U.S. hospital laboratory technologists have very limited expe
36 emographics, physiologic variables, standard hospital laboratory tests, and circulating cytokine conc
37 gration of demographics, bedside physiology, hospital laboratory tests, and circulating cytokines pre
38 erial input, including patient demographics, hospital laboratory tests, and plasma concentrations of
39  reagent volumes when compared with standard hospital laboratory tests.
40                                         Only hospital laboratories that either reported fewer than 50
41                     In 1995, a 20% sample of hospital laboratories that responded to the initial ques
42      Study participants were referred to the hospital laboratory to test their blood group.
43                                         Most hospital laboratories use commercial tests to detect res
44  prospective data collection with linkage to hospital laboratories via automated feeds of 371 patient
45 these recommended methods were being used in hospital laboratories was needed.
46 h Cryptosporidium oocysts were recognized by hospital laboratories were collected from 218 patients w
47 s and drug susceptibility data directly from hospital laboratories, whereas the CDC-sponsored system
48  be due to the culturing methods employed in hospital laboratories, which are unable to detect the un
49      The majority of testing is performed by hospital laboratories with an expected turnaround time o